 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Fatal Inflammatory Condition in a Patient with a Variant Bacterial Strain
18 September 2001 | Volume 135 Issue 6 | Page S41
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay." It is in the 18 September 2001 issue of Annals of Internal Medicine (volume 135, pages 434-438). The authors are S Johnson, SA Kent, KJ O'Leary, MM Merrigan, SP Sambol, LR Peterson, and DN Gerding.
What is the problem and what is known about it so far?
Pseudomembranous colitis is an uncommon but serious inflammation of the colon that can cause diarrhea, dehydration, and even death. It occurs in some people who have been given antibiotics. These drugs destroy harmless bacteria already in the colon that prevent the growth of disease-causing organisms. Subsequent growth of a particular organism, Clostridium difficile, can cause pseudomembranous colitis. This organism produces A and B toxins that can be measured in stool samples. Doctors usually use stool tests that measure toxin A to diagnose colitis rather than stool cultures because cultures often test positive for this organism in people without colitis. Whether the stool tests that are commonly used to detect clostridium toxins miss important strains (types) of clostridium is not well known.
Why did the researchers do this particular study?
To describe routinely available tests for Clostridium difficile toxins and the type of clostridium toxin that was missed in a patient with fatal pseudomembranous colitis.
Who was studied?
One 86-year-old man who died of pseudomembranous colitis after taking antibiotics for pneumonia. The man had had negative results on repeated stool tests for toxin A.
How was the study done?
The researchers used molecular techniques to analyze the clostridium recovered from the man's stool specimens. They also asked staff members at 67 laboratories in the Chicago area to describe the tests used at their laboratories to detect this organism.
What did the researchers find?
Analysis of stool specimens showed a variant strain of Clostridium difficile that did not produce toxin A. Nearly half of the regional laboratories surveyed were using only stool tests for toxin A to detect this organism.
What were the limitations of the study?
The findings relate to a single patient. The study did not determine whether pseudomembranous colitis is frequently caused by variant strains of this clostridium that are not detected with commonly used laboratory tests.
What are the implications of the study?
Variant strains of Clostridium difficile that are not detected with common stool tests for toxin A can cause pseudomembranous colitis.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  B.-M. Shin, E. Y. Kuak, H. M. Yoo, E. C. Kim, K. Lee, J.-O. Kang, D. H. Whang, and J.-H. Shin Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005 J. Med. Microbiol., June 1, 2008; 57(6): 697 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Samie, C. L. Obi, J. Franasiak, L. Archbald-Pannone, P. O. Bessong, C. Alcantara-Warren, and R. L. Guerrant PCR Detection of Clostridium difficile Triose Phosphate Isomerase (tpi), Toxin A (tcdA), Toxin B (tcdB), Binary Toxin (cdtA, cdtB), and tcdC Genes in Vhembe District, South Africa Am J Trop Med Hyg, April 1, 2008; 78(4): 577 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Novak-Weekley and M. H. Hollingsworth Comparison of the Premier Toxin A and B Assay and the TOX A/B II Assay for Diagnosis of Clostridium difficile Infection Clin. Vaccine Immunol., March 1, 2008; 15(3): 575 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Crabtree, D. Aitchison, B. F. Meyers, H. Tymkew, J. R. Smith, T. J. Guthrie, N. Munfakh, M. R. Moon, M. K. Pasque, J. Lawton, et al. Clostridium Difficile in Cardiac Surgery: Risk Factors and Impact on Postoperative Outcome Ann. Thorac. Surg., April 1, 2007; 83(4): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Hamm, D. E. Voth, and J. D. Ballard Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication PNAS, September 19, 2006; 103(38): 14176 - 14181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Ticehurst, D. Z. Aird, L. M. Dam, A. P. Borek, J. T. Hargrove, and K. C. Carroll Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin. J. Clin. Microbiol., March 1, 2006; 44(3): 1145 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Voth and J. D. Ballard Clostridium difficile Toxins: Mechanism of Action and Role in Disease Clin. Microbiol. Rev., April 1, 2005; 18(2): 247 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pituch, M. Rupnik, P. Obuch-Woszczatynski, A. Grubesic, F. Meisel-Mikolajczyk, and M. Luczak Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland J. Med. Microbiol., February 1, 2005; 54(2): 143 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Geric, M. Rupnik, D. N. Gerding, M. Grabnar, and S. Johnson Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital J. Med. Microbiol., September 1, 2004; 53(9): 887 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. van den Berg, E. C. J. Claas, D. H. Oyib, C. H. W. Klaassen, L. Dijkshoorn, J. S. Brazier, and E. J. Kuijper Characterization of Toxin A-Negative, Toxin B-Positive Clostridium difficile Isolates from Outbreaks in Different Countries by Amplified Fragment Length Polymorphism and PCR Ribotyping J. Clin. Microbiol., March 1, 2004; 42(3): 1035 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pituch, A. van Belkum, N. van den Braak, P. Obuch-Woszczatynski, H. Verbrugh, F. Meisel-Mikolajczyk, and M. Luczak Recent Emergence of an Epidemic Clindamycin-Resistant Clone of Clostridium difficile among Polish Patients with C. difficile-Associated Diarrhea J. Clin. Microbiol., September 1, 2003; 41(9): 4184 - 4187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Johnson, S. P. Sambol, J. S. Brazier, M. Delmee, V. Avesani, M. M. Merrigan, and D. N. Gerding International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants J. Clin. Microbiol., April 1, 2003; 41(4): 1543 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aboudola, K. L. Kotloff, L. Kyne, M. Warny, E. C. Kelly, S. Sougioultzis, P. J. Giannasca, T. P. Monath, and C. P. Kelly Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A Infect. Immun., March 1, 2003; 71(3): 1608 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rupnik, N. Kato, M. Grabnar, and H. Kato New Types of Toxin A-Negative, Toxin B-Positive Strains among Clostridium difficile Isolates from Asia J. Clin. Microbiol., March 1, 2003; 41(3): 1118 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Wilkins and D. M. Lyerly Clostridium difficile Testing: after 20 Years, Still Challenging J. Clin. Microbiol., February 1, 2003; 41(2): 531 - 534. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Belanger, M. Boissinot, N. Clairoux, Francois. J. Picard, and M. G. Bergeron Rapid Detection of Clostridium difficile in Feces by Real-Time PCR J. Clin. Microbiol., February 1, 2003; 41(2): 730 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. B. Deming and E. S. Hyman Colitis Associated with Variant Clostridium difficile Ann Intern Med, August 20, 2002; 137(4): 297 - 298. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Bartlett Antibiotic-Associated Diarrhea N. Engl. J. Med., January 31, 2002; 346(5): 334 - 339. [Full Text] [PDF]
|
|
|
|
 |
|
 Diagnosing Pseudomembranous Colitis: C'est Difficile Journal Watch Infectious Diseases, October 4, 2001; 2001(1004): 4 - 4. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
